Bioinformatics analyses reveal the role of RIPK1 in clear cell renal cell carcinoma
Authors:
Open Access
- 28 February 2026
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Abstract
Receptor interacting protein kinase 1 (RIPK1) is crucial in the regulation of apoptosis; however, its significance in clear cell renal cell carcinoma (ccRCKeywords
Funding Information
- the Science and Technology Innovation Project of Songjiang District, Shanghai (2025SJKJGG43)
- by the Key Discipline Construction Project of Songjiang District, Shanghai (2025czys011)
This publication has 41 references indexed in Scilit:
- Predicting CTLA4 expression and prognosis in clear cell renal cell carcinoma using a pathomics signature of histopathological images and machine learningHeliyon, 2024
- A nomogram based on 4-lncRNAs signature for improving prognostic prediction of hepatocellular carcinomaClinical and Translational Oncology, 2023
- Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironmentsCancer Cell, 2022
- RIP1-dependent linear and nonlinear recruitments of caspase-8 and RIP3 respectively to necrosome specify distinct cell death outcomesProtein & Cell, 2021
- PI3K mediates tumor necrosis factor induced-necroptosis through initiating RIP1-RIP3-MLKL signaling pathway activationCytokine, 2020
- RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation EventsTrends in Cell Biology, 2020
- Epidemiology of Renal Cell CarcinomaEuropean Urology, 2018
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint BlockadeCell Reports, 2017
- RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3Cell, 2014
- RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell deathCell, 1995